BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11582807)

  • 1. Intracellular applications of ribozymes.
    Michienzi A; Rossi JJ
    Methods Enzymol; 2001; 341():581-96. PubMed ID: 11582807
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
    Bramlage B; Luzi E; Eckstein F
    Nucleic Acids Res; 2000 Nov; 28(21):4059-67. PubMed ID: 11058100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribozyme expression systems.
    Sano M; Taira K
    Methods Mol Biol; 2004; 252():195-207. PubMed ID: 15017050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of catalytic parameters for hairpin ribozymes.
    DeYoung MB; Siwkowski A; Hampel A
    Methods Mol Biol; 1997; 74():209-20. PubMed ID: 9204436
    [No Abstract]   [Full Text] [Related]  

  • 5. Design of hybridizing arms in hammerhead ribozymes.
    Hendry P; McCall MJ; Lockett TJ
    Methods Mol Biol; 1997; 74():253-64. PubMed ID: 9204440
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimized hammerhead ribozymes.
    McCall MJ; Hendry P; Lockett TJ
    Methods Mol Biol; 1997; 74():151-9. PubMed ID: 9204430
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of hairpin ribozymes for in vitro and cellular applications.
    Yu Q; Burke JM
    Methods Mol Biol; 1997; 74():161-9. PubMed ID: 9204431
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of ribozymes against the bcr-abl mRNAs in vitro.
    James HA; Twomey CM; Mills KI; Gibson I
    Biochem Soc Trans; 1996 Aug; 24(3):409S. PubMed ID: 8878953
    [No Abstract]   [Full Text] [Related]  

  • 9. Trans-splicing reactions by ribozymes.
    Jones JT; Lee SW; Sullenger BA
    Methods Mol Biol; 1997; 74():341-8. PubMed ID: 9204448
    [No Abstract]   [Full Text] [Related]  

  • 10. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of hammerhead ribozyme cleavage by RT-PCR methods.
    Perriman R
    Methods Mol Biol; 1997; 74():301-9. PubMed ID: 9204445
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.
    Amarzguioui M; Brede G; Babaie E; Grotli M; Sproat B; Prydz H
    Nucleic Acids Res; 2000 Nov; 28(21):4113-24. PubMed ID: 11058107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozymes.
    Steinecke P; Schreier PH
    Methods Cell Biol; 1995; 50():449-60. PubMed ID: 8531816
    [No Abstract]   [Full Text] [Related]  

  • 16. Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate.
    Goodchild J; Kohli V
    Arch Biochem Biophys; 1991 Feb; 284(2):386-91. PubMed ID: 1989522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.
    Bramlage B; Alefelder S; Marschall P; Eckstein F
    Nucleic Acids Res; 1999 Aug; 27(15):3159-67. PubMed ID: 10454613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hammerhead ribozyme targeted to the human chemokine receptor CCR5.
    González MA; Serrano F; Llorente M; Abad JL; García-Ortiz MJ; Bernad A
    Biochem Biophys Res Commun; 1998 Oct; 251(2):592-6. PubMed ID: 9792818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporter ribozymes for real-time analysis of domain-specific interactions in biomolecules: HIV-1 reverse transcriptase and the primer-template complex.
    Hartig JS; Famulok M
    Angew Chem Int Ed Engl; 2002 Nov; 41(22):4263-6. PubMed ID: 12434357
    [No Abstract]   [Full Text] [Related]  

  • 20. Ribozymes.
    Rossi JJ
    Curr Opin Biotechnol; 1992 Feb; 3(1):3-7. PubMed ID: 1368020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.